Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Asubio Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01496885
First received: December 19, 2011
Last updated: June 6, 2013
Last verified: June 2013

December 19, 2011
June 6, 2013
November 2011
May 2013   (final data collection date for primary outcome measure)
Evaluate the Simplified STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Obtained Between 24 and 48 Hours of a Nonhemorrhagic Ischemic Stroke [ Time Frame: Up to 84 days ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01496885 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
A Multicenter Observational Study to Evaluate the Simplified STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Obtained Between 24 and 48 Hours of a Nonhemorrhagic Ischemic Stroke

The purpose of this study is to evaluate the utility of the S-STREAM as an instrument to assess motor function in subjects who have experienced a nonhemorrhagic ischemic stroke.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Subjects may be selected upon admission to an acute care emergency center, inpatient facility, or rehabilitation center.

  • Nonhemorrhagic Ischemic Stroke
  • Motor Function
Not Provided
Nonhemorrhagic Ischemic Stroke
Subjects obtained within 24 to 48 hours of a nonhemorrhagic ischemic stroke
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
May 2013
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male or female subjects between 21 and 85 years, inclusive
  • Subjects obtained between 24 and 48 hours of a nonhemorrhagic ischemic stroke
  • Total score between 20 and 85 on the S-STREAM administered between 24 and 48 hours after stroke onset

Exclusion Criteria:

  • History of previous stroke; uncontrolled severe hypertension; dementia; advanced Parkinson disease or other significant movement disorders
  • Development of hemodynamic instability following the stroke
  • Abnormal clinical laboratory values on routine clinical laboratory testing
  • History of drug or alcohol abuse
  • Current participation in another clinical study involving study drug
Both
21 Years to 85 Years
No
Contact information is only displayed when the study is recruiting subjects
United States,   Canada
 
NCT01496885
ASBI 801
No
Asubio Pharmaceuticals, Inc.
Asubio Pharmaceuticals, Inc.
Not Provided
Not Provided
Asubio Pharmaceuticals, Inc.
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP